Norway Secures Corona Medicine Through EU Agreement

Mamos Media

The EU Commission signed on Tuesday an appointment with legemiddelselskapet Gilead about enough remdesivir for the treatment of around 30, 000 corona patients. Norway is also covered by the agreement.

The contract has a value of €63 Million euros and will provide treatment to around 30, 000 patients with severe symptoms. Testing has shown that the medicine can short down the sykdomsforløpe.

leave a reply